CLUSTER filed Sep 14, 2026 at 18:03 ET
Two insiders at Revolution Medicines executed a cluster of open-market sales totaling ~$6.5M over three days, with the bulk from C-suite executive Anthony Mancini ($3.15M) and director Lorence Kim ($3.59M). The sales follow option exercises by Mancini at $33.62/share, locking in massive gains at current ~$205 prices. At a $43.7B market cap, the total represents ~0.015%, well below the 0.1% materiality threshold, making this a routine liquidity event rather than an informed bearish signal. The cluster is amplified by the cross-filing insider-trades context, but the proportionality check overrides: the dollar amount is trivial relative to company size.